As expected, in ER +ve cases, the low expression of SRSF5 was significantly associated with TAM resistance (p = 0.015; Figure 5C) and local cancer recurrence (p = 0.024; Figure 5D) and metastasis (p = 0.002; Figure 5E) as indicated by a chi-square test. This evidence concerns the gene SRSF5 and cancer.